Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001763494-26-000001 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 28, 2026 |
| Document Date | Jan 23, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
180,000
Total Value
$2,732,734.22
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 23, 2026 | Exercise/Conversion | 8,135 | $15.46 | $125,767.10 | 427,308 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 23, 2026 | Sale | 8,135 | $30.01 | $244,153.31 | 419,173 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 27, 2026 | Exercise/Conversion | 51,865 | $15.46 | $801,832.90 | 471,038 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 27, 2026 | Sale | 51,865 | $30.10 | $1,560,980.91 | 419,173 | Direct | โ | View Details | |
Director | Employee stock option (right to buy) | Derivative | Jan 23, 2026 | Exercise/Conversion | 8,135 | $0.00 | $0.00 | 171,865 | Direct | โ | View Details | |
Director | Employee stock option (right to buy) | Derivative | Jan 27, 2026 | Exercise/Conversion | 51,865 | $0.00 | $0.00 | 120,000 | Direct | โ | View Details |